Literature DB >> 8193376

Fractionated versus single-dose total body irradiation at low and high dose rates to condition canine littermates for DLA-identical marrow grafts.

R Storb1, R F Raff, F R Appelbaum, H J Deeg, T C Graham, F G Schuening, G Sale, E Bryant, K Seidel.   

Abstract

We explored in dogs the immunosuppressive properties of 450 cGy total body irradiation (TBI) delivered from two opposing 60Co sources, as assessed by the criterion of successful engraftment of allogeneic genotypically DLA-identical littermate marrow. Two questions were asked in this study. Firstly, does dose rate affect the immunosuppressive effect of TBI when administered in a single dose? Secondly, does fractionation alter the immunosuppression of TBI when delivered at a very fast dose rate? Dose rates studied included 7 and 70 cGy/min, and fractionation involved four fractions of 112.5 cGy each, with 6-hour minimum interfraction intervals. Six of 7 dogs receiving 450 cGy single-dose TBI at 70 cGy/min showed sustained engraftment of the allogeneic marrow, compared with 1 of 7 dogs receiving single-dose TBI at 7 cGy/min (P = .01). Fractionated TBI at 70 cGy/min resulted in sustained allogeneic engraftment in 3 of 10 dogs, a result that was statistically significantly worse than that with single-dose TBI at 70 cGy/min (P = .03) and not statistically different (P = .24) from that with fractionated TBI delivered at 7 cGy/min (0 of 5 dogs engrafted). A single dose of 450 cGy of TBI delivered at a rate of 70 cGy/min is significantly more immunosuppressive than the same total dose delivered at 7 cGy/min. Fractionated TBI at 70 cGy/min is significantly less immunosuppressive than single-dose TBI at 70 cGy/min and not significantly different from fractionated TBI administered at 7 cGy/min. Results are consistent with the notion that significant DNA repair in lymphoid cells is possible during interfraction intervals at the relatively high dose rate of 70 cGy/min.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8193376

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  10 in total

Review 1.  The hematopoietic system in the context of regenerative medicine.

Authors:  Christopher D Porada; Anthony J Atala; Graça Almeida-Porada
Journal:  Methods       Date:  2015-08-28       Impact factor: 3.608

2.  Comparing high and low total body irradiation dose rates for minimum-intensity conditioning of dogs for dog leukocyte antigen-identical bone marrow grafts.

Authors:  Scott S Graves; Barry E Storer; Tiffany M Butts; Rainer Storb
Journal:  Biol Blood Marrow Transplant       Date:  2013-08-28       Impact factor: 5.742

Review 3.  Evaluating biomarkers to model cancer risk post cosmic ray exposure.

Authors:  Deepa M Sridharan; Aroumougame Asaithamby; Steve R Blattnig; Sylvain V Costes; Paul W Doetsch; William S Dynan; Philip Hahnfeldt; Lynn Hlatky; Yared Kidane; Amy Kronenberg; Mamta D Naidu; Leif E Peterson; Ianik Plante; Artem L Ponomarev; Janapriya Saha; Antoine M Snijders; Kalayarasan Srinivasan; Jonathan Tang; Erica Werner; Janice M Pluth
Journal:  Life Sci Space Res (Amst)       Date:  2016-05-21

Review 4.  Increased intensity lymphodepletion and adoptive immunotherapy--how far can we go?

Authors:  Pawel Muranski; Andrea Boni; Claudia Wrzesinski; Deborah E Citrin; Steven A Rosenberg; Richard Childs; Nicholas P Restifo
Journal:  Nat Clin Pract Oncol       Date:  2006-12

5.  Investigation of immunological approaches to enhance engraftment in a 1 Gy TBI canine hematopoietic stem cell transplantation model.

Authors:  Sandra Lange; Simone Altmann; Bettina Brandt; Carsten Adam; Franziska Riebau; Heike Vogel; Volker Weirich; Inken Hilgendorf; Rainer Storb; Mathias Freund; Christian Junghanss
Journal:  Exp Hematol       Date:  2009-01       Impact factor: 3.084

6.  Early outcomes after allogeneic hematopoietic SCT in pediatric patients with hematologic malignancies following single fraction TBI.

Authors:  T E Druley; R Hayashi; D B Mansur; Q Jean Zhang; Y Barnes; K Trinkaus; S Witty; T Thomas; E E Klein; J F DiPersio; D Adkins; S Shenoy
Journal:  Bone Marrow Transplant       Date:  2008-11-17       Impact factor: 5.483

7.  Salvage allogeneic hematopoietic cell transplantation with fludarabine and low-dose total body irradiation after rejection of first allografts.

Authors:  Boglarka Gyurkocza; Thai M Cao; Rainer F Storb; Thoralf Lange; Wendy Leisenring; Georg N Franke; Mohamed Sorror; Richard Hoppe; David G Maloney; Robert S Negrin; Judith A Shizuru; Brenda M Sandmaier
Journal:  Biol Blood Marrow Transplant       Date:  2009-08-03       Impact factor: 5.742

8.  Total body irradiation dose escalation decreases risk of progression and graft rejection after hematopoietic cell transplantation for myelodysplastic syndromes or myeloproliferative neoplasms.

Authors:  Federico Monaco; Bart L Scott; Thomas R Chauncey; Finn B Petersen; Barry E Storer; Frederic Baron; Mary E Flowers; H Joachim Deeg; David G Maloney; Rainer Storb; Brenda M Sandmaier
Journal:  Haematologica       Date:  2019-01-10       Impact factor: 9.941

9.  Late infusion of cloned marrow fibroblasts stimulates endogenous recovery from radiation-induced lung injury.

Authors:  Mineo Iwata; David K Madtes; Kraig Abrams; Wayne J E Lamm; Robb W Glenny; Richard A Nash; Aravind Ramakrishnan; Beverly Torok-Storb
Journal:  PLoS One       Date:  2013-03-08       Impact factor: 3.240

10.  Total Body Irradiation for Hematopoietic Stem Cell Transplantation: What Can We Agree on?

Authors:  Mitchell Sabloff; Steven Tisseverasinghe; Mustafa Ege Babadagli; Rajiv Samant
Journal:  Curr Oncol       Date:  2021-02-14       Impact factor: 3.677

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.